Three vaccines are being developed to address a rare Ebola strain, which has already claimed nearly 250 lives and poses the risk of becoming the worst outbreak recorded.
The move comes as fears grow that this outbreak could be the worst in history
Jun 02, 2026
03:09 pm
What's the storyThe International AIDS Vaccine Initiative (IAVI), the University of Oxford, and pharmaceutical giant Moderna are all working on vaccines for the Bundibugyo species of Ebola.
The move comes as fears grow that this outbreak could be the worst in history.
'We need to act now': Race to develop Ebola vaccine heats up
Moderna receives $50 million to develop Ebola vaccine as number of cases surge
Health body fast-tracks three Ebola vaccines as virus continues spread
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
Race to develop Ebola vaccine as deadly strain of virus spreads
Moderna and other groups get $60m to develop Ebola vaccine
Scientists target human trials for new Ebola vaccine 'within months'
Moderna and other groups get $60 million to develop Ebola vaccine - Middle East and Africa - The Jakarta Post
Ebola: $62 million pledge to speed up vaccine development
Race for Ebola vaccine gets $50m boost as medics struggle to trace contacts | The National
While it marks the 17th Ebola outbreak in the DRC, it is just the third caused by the Bundibugyo strain, for which there are no...
A new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic…
This initiative is crucial as health authorities worldwide race to identify medical options and contain the outbreak, which has…
The Bundibugyo strain of Ebola has a fatality rate of up to 50 percent and no approved vaccine as yet.
Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in…
Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.
